128 results
Page 3 of 7
8-K
EX-99.1
9e489ov 2p2ocwy6x
23 Sep 22
NanoVibronix UroShield Approved for Sale through NHS Internal
8:30am
8-K
EX-99.1
sy0zt2te0b7 73
14 Sep 22
NanoVibronix Announces Distribution of Series F Preferred Stock to Holders of its Common Stock
10:21am
8-K
EX-99.1
am3c12
2 Sep 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:30pm
8-K
EX-99.1
6abdxbo045s70ew5h
17 May 22
Nanovibronix Reports First Quarter 2022 Financial Results
8:30am
8-K
EX-99.1
2aapqgj
14 Jan 22
NanoVibronix Expands Board of Directors with Appointment of Two New
11:19am
DEFA14A
lhdz6
21 Dec 21
Additional proxy soliciting materials
11:15am
8-K
EX-99.1
fc46ag
12 Oct 21
Nanovibronix Announces Positive Results from
9:00am
8-K
EX-99.1
82l swoe4hje
17 Aug 21
Nanovibronix Announces Results of Annual Meeting of Stockholders Held Today
3:59pm
8-K
EX-99.1
39yq3t88v2x7ek90io
17 Aug 21
Provides Business Update
9:00am
DEFR14A
p4f36evg14apvos94r3
2 Jul 21
Revised proxy
6:10am
8-K
EX-99.1
q289bp6ga ahswswfn8n
3 Jun 21
NanoVibronix Provides Business Update
6:15am
PRER14A
w7eilkgjbx
28 May 21
Preliminary revised proxy
2:32pm